EUVIMEDEUVIMED entdecken
Crossref

COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience

Demet Baltu iD, Eda Didem Kurt-Sukur, Tugba Tastemel Ozturk, Bora Gulhan, Fatih Ozaltin, Ali Duzova, Rezan Topaloglu

Klinische Pädiatrie · 01.01.2026 · 238 (01) · 14-20

DOI: 10.1055/a-2319-2648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.01.2026. Verfasst von Demet Baltu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Renal Insufficiency, Chronic, COVID-19. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Following the pandemic of COVID-19, the main focus has been on COVID-19 vaccines and herd immunity. Although the safety of the COVID-19 vaccines has been shown in clinical trials, children with chronic diseases were not included. We investigated the side effect profile and safety of the COVID-19 vaccines in adolescents with kidney disease.

Methods

A questionnaire including demographic information, history of COVID-19, vaccination status, and vaccine-related side effects was administered to the patients with chronic kidney disease (CKD) stage 2–5, glomerular disease treated with immunosuppression, and kidney transplant recipients.

Results

Ninety-eight patients were vaccinated with CoronaVac-inactivated SARS-CoV-2 (n=16) or BNT162b2 messenger RNA (mRNA) COVİD-19 (n=82) vaccine. The mean age was 16.90±2.36 years. The most common side effects were local pain, fatigue, and fever. No serious side effects or renal disease flare were observed. There was no significant difference in the side effects reported after the BNT162b2 mRNA-RNA as compared to the Corona Vac-inactivated SARS-CoV-2 vaccine. No significant relationship was found between the frequency of side effects according to age, glomerular filtration rate, immunosuppressive treatments, CKD stage, and the underlying disease.

Conclusion

Although the reported data are subjective because they were obtained through a questionnaire and studies with long-term follow-up are needed, our early experience suggests that the vaccine is safe and adolescents and young adults should be encouraged to be vaccinated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesRenal Insufficiency, ChronicCOVID-19HumansAdolescentMaleFemaleYoung AdultBNT162 VaccineKidney TransplantationChildImmunosuppressive AgentsSurveys and QuestionnairesSARS-CoV-2Vaccination

Substanzen

COVID-19 VaccinesBNT162 VaccineImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pediatric Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Demet Baltu

Zitieren

APA

Baltu, D., Kurt-Sukur, E. D., Tastemel Ozturk, T., Gulhan, B., Ozaltin, F., Duzova, A., & Topaloglu, R. (2026). COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience. Klinische Pädiatrie, 238(01), 14-20. https://doi.org/10.1055/a-2319-2648

Vancouver

Baltu D, Kurt-Sukur ED, Tastemel Ozturk T, Gulhan B, Ozaltin F, Duzova A, et al. COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience. Klinische Pädiatrie. 2026;238(01):14-20. doi:10.1055/a-2319-2648

BibTeX
@article{Baltu2026,
  author = {Baltu, Demet and Kurt-Sukur, Eda Didem and Tastemel Ozturk, Tugba and Gulhan, Bora and Ozaltin, Fatih and Duzova, Ali and Topaloglu, Rezan},
  title = {COVID-19 vaccination among adolescents and young adults with chronic kidney conditions: a single-center experience},
  journal = {Klinische Pädiatrie},
  year = {2026},
  volume = {238},
  number = {01},
  pages = {14--20},
  doi = {10.1055/a-2319-2648}
}
Kostenlos starten →